A validation of the approach An ab initio molecular dynamics ...A validation of the approach Harsh...
Transcript of A validation of the approach An ab initio molecular dynamics ...A validation of the approach Harsh...
An ab initio molecular dynamics method for cocrystal prediction:
A validation of the approach
Harsh Baruaa, Anilkumar Gunnamb, Balvant Yadava, Ashwini Nangiab, and Nalini Shastri*a
*Corresponding author
a Solid State Pharmaceutical Research Group (SSPRG), Department of Pharmaceutics,
National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037,
India
Tel. +91-040-23423749 14
Fax. +91-040-23073751 15
E-mail: [email protected], [email protected]
b School of Chemistry, University of Hyderabad, Prof. C. R. Rao Road, Gachibowli, Central
University P.O., Hyderabad 500 046, India
Electronic Supporting Information
Electronic Supplementary Material (ESI) for CrystEngComm.This journal is © The Royal Society of Chemistry 2019
Benzamide
Physical mixture
Cocrystal
Nitrofurantoin
%T
1777.01
3363.68
3368.7 1778
3475.641744
Carbonyl stretching
Carbonyl stretching
Carbonyl stretching
Amide stretching
Amide stretching
Amide stretching
Figure S1: Infrared spectrum overlay for nitrofurantoin-benzamide cocrystal
Isonicotinamide
Physical mixture
Cocrystal
Nitrofurantoin
%T
1803
3434.30
18043372
18123410.37Carbonyl stretching
Carbonyl stretching
Carbonyl stretching
Amide stretching
Amide stretching
Amide stretching
Figure S2: Infrared spectrum overlay for nitrofurantoin-isonicotinamide cocrystal
Ferulic acid
Physical mixture
Cocrystal
Nitrofurantoin
%T
1803.77
1777.01
1800.63434.30
1778.01
3444.80
1826.87
1780.01
3434.30
Carbonyl stretching
Hydroxyl stretching
Carbonyl stretching Hydroxyl
stretching
Hydroxyl stretching
Carbonyl stretching
Figure S3: Infrared spectrum overlay for nitrofurantoin-ferulic acid cocrystal
Salicylamide
Physical mixture
Cocrystal
Nitrofurantoin
3276
16722
32801673.43
1736.87
3395
%T
Imide stretching
Imide stretching
Imide stretching Carbonyl stretching
Carbonyl stretching
Carbonyl stretching
Figure S4: Infrared spectrum overlay for nitrofurantoin-salicylamide cocrystal
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-benzoic acid system
Benzoic acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-caffeine system
Caffeine
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-chrysin system
Chrysin
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin- 2,4-dihydroxy benzoic acid system
2,4-Dihydroxy benzoic acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-fumaric acid system
Fumaric acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-glutaric acid system
Glutaric acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-nicotinic acid system
Nicotinic acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-isonicotinic acid system
Isonicotinic acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-malic acid system
Malic acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-maleic acid system
Maleic acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-malonic acid system
Malonic acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-quercetin system
Quercetin
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-sebacic acid system
Sebacic acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-succinic acid system
Succinic acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-syringic acid system
Syringic acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin-tartaric acid system
Tartaric acid
Inte
nsity
2Ɵ
Nitrofurantoin
Nitrofurantoin- p-coumaric acid system
p-coumaric acid
Figure S5: Powder X-ray diffraction overlay for generated cogrinded samples with nitrofurantoin and respective coformer